
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇨🇦CA · Science#1325K to 30K
- 🇹🇼TW · Science#773K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
4K to 20K🎙 ~2x weekly·66 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
8K to 40K🇨🇦75%🇹🇼25% - Active Followers
Loyal subscribers who consistently listen
3.2K to 16K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
S5E6: Confounding is the Marcia Brady of Epidemiology
Jun 15, 2026
Unknown duration
S5E5: Causal Pies, Pizza Toppings, and Interaction
May 15, 2026
44m 01s
S5E4: Mind the Modifier: When Causal Effects Refuse to Be Average
Apr 15, 2026
55m 33s
S5E3: From Cashew Nuts to Counterfactuals
Mar 15, 2026
55m 33s
S5E2: Setting the table for Season 5
Feb 15, 2026
51m 17s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/15/26 | ![]() S5E6: Confounding is the Marcia Brady of Epidemiology | “Confounding, Confounding, Confounding” is like the epidemiologist’s version of “Marcia, Marcia, Marcia” from the Brady Bunch. To discuss Chapter 7 of Causal Inference: What If, we welcome Dr. Ashley Naimi. In this chapter, we discuss confounding as a central problem when estimating causal effects from observational data. The chapter emphasizes that confounding is not just an imbalance in covariates across exposure groups, but a causal problem that depends on the underlying structure of how treatment, outcome, and other variables are related. In this episode, Dr. Naimi helps explain concepts related to confounding, exchangeability, and faithfulness. We (try to) talk through confounding-related DAGs and how they are a useful tool to understand confounding bias. This episode shows why confounding gets so much attention in epidemiology: it is everywhere, often misunderstood, and, like Marcia Brady, it has a way of stealing the spotlight. | — | ||||||
| 5/15/26 | ![]() S5E5: Causal Pies, Pizza Toppings, and Interaction✨ | causal interactioneffect measure modification+5 | Dr. John Jackson | Causal Inference: What If? | — | causal interactioneffect measure modification+6 | — | 44m 01s | |
| 4/15/26 | ![]() S5E4: Mind the Modifier: When Causal Effects Refuse to Be Average✨ | effect modificationheterogeneity of treatment effects+4 | Dr. Mabel Carabali | Causal Inference: What If | — | causal effectseffect modification+5 | — | 55m 33s | |
| 3/15/26 | ![]() S5E3: From Cashew Nuts to Counterfactuals✨ | causal inferenceobservational studies+5 | Dr. Peter Tennant | Causal Inference: What If | — | causal inferenceobservational studies+7 | — | 55m 33s | |
| 2/15/26 | ![]() S5E2: Setting the table for Season 5✨ | causal inferenceidentifiability assumptions+5 | — | Causal Inference: What If | — | causal inferenceidentifiability+6 | — | 51m 17s | |
| 1/15/26 | ![]() S5E1: A Casual Conversation with Miguel Hernán✨ | Causal InferenceEpidemiology+4 | Miguel Hernán | Society for Epidemiologic Research | — | Causal InferenceEpidemiology+5 | — | 31m 26s | |
| 8/15/25 | ![]() S4E13: Agent Based Models✨ | agent based modelsepidemiology+4 | — | — | — | agent based modelsepidemiology+4 | — | 50m 25s | |
| 7/15/25 | ![]() S4E12: Agent Based Models with Dr. Brandon Marshall✨ | Agent Based Modelsepidemiology+5 | Dr. Brandon Marshall | Brown School of Public Health | — | Agent Based Modelsepidemiology+5 | — | 1h 00m 41s | |
| 6/15/25 | ![]() S4E11: Quantitative Bias Analysis✨ | Quantitative Bias Analysismeasurement error+3 | — | Society for Epidemiologic Research | — | Quantitative Bias Analysismeasurement error+3 | — | 47m 42s | |
| 5/15/25 | ![]() S4E10: Quantitative Bias Analysis with Dr. Tim Lash✨ | Quantitative Bias Analysisnon-random error+4 | Dr. Timothy Lash | Emory UniversitySociety for Epidemiologic Research | — | Quantitative Bias Analysisnon-random error+5 | — | 58m 55s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/15/25 | ![]() S4E9: Regression Discontinuity and Difference in Difference(s?)✨ | regression discontinuitydifference in difference+3 | — | Society for Epidemiologic Research | — | regression discontinuitydifference in difference+5 | — | 52m 16s | |
| 3/15/25 | ![]() S4E8: Regression Discontinuity and Difference-in-Differences with Dr. Usama Bilal | In this episode we talk to Dr. Usama Bilal of Drexel University about Regression Discontinuity Design (RDD) and Difference-in-Differences (DiD), two quasi experimental methods that fall under the instrumental variables framework which we discussed in previous episodes. We talk about what RDD is, the different types (fuzzy vs sharp) and what we are actually estimating (LATE vs CACE). We talk about the bias vs variance tradeoff in how far from the threshold we choose to draw inferences. We talk about the assumptions that are needed for these methods to give valid estimate of effects. Then we talk about DiD and how this is a form of RDD with a second group that does not experience the discontinuity as a control. And we talk about the additional assumptions needed for this approach (e.g. parallel trends). | — | ||||||
| 2/15/25 | ![]() S4E7: Instrumental Variables | In this episode, Hailey and Matt discuss whether IVs are rebellious or magical or the midlife crisis of methods. We talk about how they deal with confounding problems. We talk about how they are used to attempt to mimic randomization and the assumptions for IVs. We talk about why it’s so helpful to think about who gets the exposure and why for causal inference. We talk about how IVs fit in with the target trial framework and wham it might tell us about how to teach intro epi. We talk about what estimand IVs estimate. And we relitigate the soda vs pop discussion. | — | ||||||
| 1/15/25 | ![]() S4E6: Instrumental Variables with Dr. Rita Hamad | In this episode, we discuss instrumental variables with Dr. Rita Hamad of Harvard’s TH Chan School of Public Health. This episode is focused on the first part of Chapter 28 of Modern Epidemiology 4th edition on quasi experimental methods. We start with what quasi experimental designs are and why we would want to use them (and whether more epidemiologists are being exposed to them). We also talk about why these methods are more common in economics than in epi. We talk about how these methods try to take advantage of something that approximates randomization to estimate causal effects. We talk about what instrumental variables are and the conditions required to be met for a variable to be an instrument. We focus on the strengths and limitations of the methods and when they make the most sense to use them. We talk about what happens when you violate the assumptions of IV. We talk about weak and strong IVs and we talk about Mendelian randomization and its role in epi. And we ask the age-old question, how do you find the elusive instrumental variable? | — | ||||||
| 12/15/24 | ![]() S4E5: Mediation Continuation | In this episode we follow up on our conversation about mediation. We talk about what mediation is and when it is useful. We talk about the history of these methods. We debate what direct and indirect effects are. We describe natural and controlled effects. We discuss the importance of the number 666 in Matt’s life. We talk about exposure mediator interaction. Matt learns what kinesiology is. We discuss proportion mediated and proportion eliminated. And we talk about the confounding assumptions needed for mediation analysis. | — | ||||||
| 11/15/24 | ![]() S4E4: Mediation with Kara Rudolph and Ivan Diaz | In this episode, Matt and Hailey talk with Dr. Kara Rudolph and Dr. Ivan Diaz about mediation analysis. We talk through what it is, what it means and when we want to do it. We talk about mechanism of causation and how mediation can help. We cover things like natural direct and indirect effects and controlled direct effects (and why there isn’t a controlled indirect effect – a thing that stumped Matt for some time). And we discuss the different assumptions need to draw valid inferences in a mediation analysis, like all the many no confounding assumptions and the cross world assumption. And we talk about what Matt refers to as mediated moderation (interaction in the effect on the outcome between the exposure and mediator). | — | ||||||
| 10/15/24 | ![]() S4E3: How do we define efficiency? | In this episode, Hailey and Matt continue on their discussion on study efficiency and realize that we think about efficiency in very different ways. We talk about the difference between statistical efficiency and cost efficiency and we each make our case for one of them being the driving force in how we design and analyze studies. It may be the biggest disagreement we’ve had yet (though maybe that was interaction).We talk about matching and its impact of efficiency and also why we do matching. And we try to understand when matching is useful. Studies mentioned in the podcast: Rothman KJ, Poole C. A strengthening programme for weak associations. Int J Epidemiol. 1988 Dec;17(4):955-9. doi: 10.1093/ije/17.4.955. PMID: 3225112. | — | ||||||
| 9/15/24 | ![]() S4E2: Study Efficiency with Robert Platt | In this episode we are joined by Professor Robert Platt of McGill University to talk about study efficiency and the ways we can think about this in terms of study design. We talk about hierarchies of evidence and its relationship to things like target validity. We get into why we think case control studies are so often misunderstood, particularly with respect to missing that they should be nested within a cohort. We talked about the varying definitions of efficient (variance, efficiency of confounding control, cost efficient, etc.) and how they relate to different study designs, and we disagreed about which definition is the most useful. And we talk about sampling and how it affects study efficiency and also what question we are asking. The paper that Rob reads over and over is: Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, Robins JM. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol. 2006;163:262-70. We also referenced: Westreich D, Edwards JK, Lesko CR, Cole SR, Stuart EA. Target Validity and the Hierarchy of Study Designs. Am J Epidemiol. 2019;188:438-443. Kramer MS, Guo T, Platt RW, Shapiro S, Collet JP, Chalmers B, Hodnett E, Sevkovskaya Z, Dzikovich I, Vanilovich I; PROBIT Study Group. Breastfeeding and infant growth: biology or bias? Pediatrics. 2002;110(2 Pt 1):343-7. | — | ||||||
| 9/3/24 | ![]() S4E1: We’re Baaaaack… A Season 4 Preview | We kick off season 4 by reminiscing about the origins of the podcast and preview what’s upcoming for season 4 where we will continue on our last season of reviewing Modern Epidemiology 4th edition. We touch on a few of the topics we are most excited about for the coming season and we preview some small formatting changes. But then we put each other through the fun questions that we ask our guests so you all can get to know us better (spoiler: Matt has no idea what the word non-fiction means). We are excited for our upcoming guests this season and the fun conversations we have in store. | — | ||||||
| 1/30/24 | ![]() S3E12: Start with the questions that are easy to answer and then move on to the more challenging questions | It’s hard to believe this is the final episode of season 3! In this season finale episode, we continue our discussion of topics related to Chapter 26 in Modern Epidemiology (4th Edition) with Dr. Eric Tchetgen Tchetgen. In this conversation we ask Dr. Tchetgen Tchetgen to help us better understand several issues related to interaction, including why it’s so important to study interaction. He provides a helpful framework for thinking about interaction: start simple and then move on to more complex questions. As part of this framework, he emphasizes the distinction between total effects and main effects, how confounding plays into conversations about interaction, and the role of scale dependence when interpretating interaction. | — | ||||||
| 1/15/24 | ![]() S3E11: You say tomato, I say tom-ah-to: a (somewhat) head-spinning discussion about interaction analyses | Matt and Hailey take a deep dive into Chapter 26 in Modern Epidemiology, 4th Edition, Analysis of Interaction. This episode needs a content warning- it is among the most advanced and conceptually complex topics we have ever covered on SERious Epi. Interaction occurs when the effect of one exposure on outcome depends in some way on the presence or absence of another exposure. Seems like a simple enough concept, right? However, as you’ll see in this episode, there are many different layers of complexity to consider related to terminology, scale, and interpretation of interaction analyses. A note from Matt and Hailey: since this material is very complex, we reached out to Dr. Jay Kaufman for his perspective on the episode before releasing it. He had some very helpful thoughts, and we would like to share them with you (paraphrasing with his permission): Part of what is confusing about this topic is the terminology differences, with Hailey using terminology (“interaction”) that lines up with that used by VanderWeele, ME4, and the Hernán and Robins textbook chapter and Matt using terminology (“interdependence”) from other articles in the literature, such as Greenland and Poole (1988). When there are joint effects that are exactly multiplicative, or supermultiplicative, you know it’s a causal interaction (i.e., synergistic or biologic interaction) because multiplicativity is necessarily super-additive as long as both exposures meet consistency, exchangeability, and positivity assumptions. However, knowing that joint effects are submultiplicative is not informative about additive interaction or synergism. It is also not possible to make a conclusion about additive interaction when a results section tells you only that in a logistic or Cox regression analysis there is “no significant interaction effect (p<0.05)” as that just tells you an effect is not exactly multiplicative. Multiplicativity has some causal implications because it is super additive as long as the causal assumptions listed above are plausibly satisfied. There are several proposed causal mechanisms that would generate multiplicative joint effects especially from the cancer epidemiology literature (e.g., Koopman 1990). In general, considering interaction on the additive scale is more useful for assessing public health relevance (e.g. Panagiotou and Wacholder 2014). Some of these concepts are difficult to convey in podcast format, so we’re including some helpful resources for anyone interested in learning more about this topic. Thanks again to Dr. Kaufman for helping us put this list together: Greenland S, Poole C. Invariants and noninvariants in the concept of interdependent effects. Scand J Work Environ Health. 1988 Apr;14(2):125-9. doi: 10.5271/sjweh.1945. PMID: 3387960. VanderWeele TJ. On the distinction between interaction and effect modification. Epidemiology. 2009 Nov;20(6):863-71. doi: 10.1097/EDE.0b013e3181ba333c. VanderWeele TJ. The Interaction Continuum. Epidemiology. 2019 Sep;30(5):648-658. doi: 10.1097/EDE.0000000000001054. PMID: 31205287; PMCID: PMC6677614. Greenland S, Poole C. Invariants and noninvariants in the concept of interdependent effects. Scand J Work Environ Health. 1988 Apr;14(2):125-9. doi: 10.5271/sjweh.1945. PMID: 3387960. Koopman JS, Weed DL. Epigenesis theory: a mathematical model relating causal concepts of pathogenesis in individuals to disease patterns in populations. Am J Epidemiol. 1990 Aug;132(2):366-90. doi: 10.1093/oxfordjournals.aje.a115666. PMID: 2372013. Panagiotou OA, Wacholder S. Invited commentary: How big is that interaction (in my community)–and in which direction? Am J Epidemiol. 2014 Dec 15;180(12):1150-8. PMID: 25395027. | — | ||||||
| 1/9/24 | ![]() S3E10: Time-varying everything everywhere all at once | In this episode, we are joined by Dr. Sonia Hernandez Diaz for a discussion on Chapter 25 in Modern Epidemiology, 4th edition. This chapter is focused on methods for causal inference in longitudinal settings, with a particular focus on time varying exposures. Dr. Hernandez-Diaz helps to explain some of the conceptual and methodological challenges related to time-varying exposures, including the advanced analytic strategies required and the careful conceptual considerations about defining the exposure of interest and causal questions. Papers referenced in this episode: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731075/ https://academic.oup.com/aje/article/183/8/758/1739860 | — | ||||||
| 10/31/23 | ![]() S3E9: Feedback loops? Feedback spirals? Disentangling what we know about time-varying exposures. | This episode is focused on Chapter 25 of Modern Epidemiology 4th edition, Causal Inference with Time Varying Exposures. In this episode, Matt and Hailey talk about how we should think about exposures that change over time. We discuss the concept of feedback loops- scenarios where the exposure affects outcome which affects a later time point of exposure and then that exposure affects a later outcome. We think about whether biologic (mechanistic) conceptualizations of feedback loop the same as the epidemiologic notion presented in the chapter. We then follow the chapter to continue our discussion about how time varying exposures change our frameworks for thinking about causal inference and analytic strategies (e.g., marginal structural models, g-formula, and structural mean models). A historical note about Andrew James Rhodes, whose picture is hanging up in the conference room that Hailey was recording from: https://discoverarchives.library.utoronto.ca/index.php/rhodes-andrew-james | — | ||||||
| 9/30/23 | ![]() S3E8: Maybe censoring is the least of your worries? | Recording from across the globe, in Melbourne, Australia, Dr. Margarita Moreno-Betancur joins us for an episode on Chapter 22 in Modern Epidemiology (4th edition) on Time-to-Event Analyses. This is a chapter focused on the methods we use when the timing of the occurrence of the event is of central importance. Dr. Moreno-Betancur answers all our questions about these types of analyses, including: the importance of the time scale, defining the origin (time zero), censoring vs. truncation. We also ask Dr. Moreno-Betancur to weigh-in on a hot take about whether the Cox Proportional Hazard model is overused in the health sciences literature. | — | ||||||
| 8/31/23 | ![]() S3E7: Are time to event analyses the Space Mountain of epidemiology? | In this episode Matt and Hailey discuss Chapter 22 of the 4th edition of Modern Epidemiology. This is a chapter focused on time to event analyses including core concepts related to time scales, censoring, and understanding rates. We discuss the issues and challenges related to time to event analyses and analytic approaches in this setting including Kaplan Meier, Cox Proportional Hazards, and other types of fancy models that are frequently taught in advanced epi courses (e.g., Weibull, Accelerated Failure Time) but infrequently used in the real-world. The chapter ends with a brief discussion of competing risks. It’s clear that Matt and Hailey need to brush up on concepts related to competing risks and semi-competing risks, and fortunately next month we’ll have an expert join us to answer all of our questions! | — | ||||||
Showing 25 of 68
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.
